- Home
- WASH vs EYPT Comparison
WASH vs EYPT Comparison
Compare WASH & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WASH | EYPT |
|---|---|---|
| Founded | 1800 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.2M | 1.5B |
| IPO Year | 1994 | 2005 |
Fundamental Metrics
Financial Performance| Metric | WASH | EYPT |
|---|---|---|
| Price | $31.97 | $13.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $30.25 | ★ $31.80 |
| AVG Volume (30 Days) | 121.7K | ★ 1.7M |
| Earning Date | 04-29-2026 | 05-18-2026 |
| Dividend Yield | ★ 6.97% | N/A |
| EPS Growth | ★ 266.26 | N/A |
| EPS | ★ 2.71 | N/A |
| Revenue | ★ $229,048,000.00 | $7,539,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.19 | $965.51 |
| P/E Ratio | $11.84 | ★ N/A |
| Revenue Growth | ★ 127.57 | N/A |
| 52 Week Low | $24.97 | $3.91 |
| 52 Week High | $37.08 | $19.11 |
Technical Indicators
Market Signals| Indicator | WASH | EYPT |
|---|---|---|
| Relative Strength Index (RSI) | 37.98 | 40.29 |
| Support Level | $26.51 | $11.88 |
| Resistance Level | $37.08 | $14.24 |
| Average True Range (ATR) | 1.09 | 1.10 |
| MACD | -0.29 | -0.39 |
| Stochastic Oscillator | 13.88 | 12.90 |
Price Performance
Historical ComparisonAbout WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.